Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

We don’t have answers for all the deadly infectious diseases in the world, a fact made painfully clear Monday as Louisiana ...

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you ...

The U.S. has developed a bird flu vaccine that can be prepared when needed. It’s not currently available because health officials haven’t deemed it necessary.

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Moderna stock (MRNA) has seen big swings this week after the first reported bird flu death in the US, which has put its development of a vaccine in focus. The stock jumped over 10% on Tuesday before ...

The CDC says the risk of bird flu to the general public is low, but public health experts say they are worried the virus could mutate and become more transmissible.

Moderna stock was on track to see a weekly gain of over 20% as of Wednesday following the first reported bird flu death in the US.

Nvidia shares are gaining 1.8%, recovering a portion of the previous day's 6.2% dive when traders' high expectations for CEO Jensen Huang's keynote speech at the CES conference were not met. Palantir ...